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Background/Objectives: To assess the iron status among European adolescents through selected biochemical parameters in a
cross-sectional study performed in 10 European cities.
Subjects/Methods: Iron status was defined utilising biochemical indicators. Iron depletion was defined as low serum ferritin
(SFo15mg/l). Iron deficiency (ID) was defined as high-soluble transferrin receptor (sTfR48.5mg/l) plus iron depletion. Iron
deficiency anaemia (IDA) was defined as ID with haemoglobin (Hb) below the WHO cutoff for age and sex: 12.0g/dl for girls
and for boys aged 12.5–14.99 years and 13.0g/dl for boys aged X15 years. Enzyme linked immunosorbent assay was used as
analytical method for SF, sTfR and C-reactive protein (CRP). Subjects with indication of inflammation (CRP 45mg/l) were
excluded from the analyses. A total of 940 adolescents aged 12.5–17.49 years (438 boys and 502 girls) were involved.
Results: The percentage of iron depletion was 17.6%, significantly higher in girls (21.0%) compared with boys (13.8%).
The overall percentage of ID and IDA was 4.7 and 1.3%, respectively, with no significant differences between boys and girls.
A correlation was observed between log (SF) and Hb (r¼0.36, Po0.01), and between log (sTfR) and mean corpuscular
haemoglobin (r¼ 0.30, Po0.01). Iron body stores were estimated on the basis of log (sTfR/SF). A higher percentage of
negative values of body iron was recorded in girls (16.5%) with respect to boys (8.3%), and body iron values tended to increase
with age in boys, whereas the values remained stable in girls.
Conclusions: To ensure adequate iron stores, specific attention should be given to girls at European level to ensure that their
dietary intake of iron is adequate.
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Introduction
Iron Deficiency (ID) continues to be one of the most
prevalent nutritional deficiencies in the world, particularly
in developing countries (World Health Organization (WHO),
2003). WHO estimated that ID occurs in about 66–80% of
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www.nature.com/ejcnthe world’s population (WHO, 2003). ID has many negative
effects on health, including changes in immune function,
cognitive development, temperature regulation, energy
metabolism and work performance (Dallman, 1986).
On the other hand, iron is a pro-oxidant and thus a possible
risk factor for coronary heart disease. However, a recent review
suggests that there is no strong association between body iron
stores and coronary heart disease in adults (Zegrean, 2009).
The diagnosis of ID is based primarily on laboratory
measurements of biochemical iron indicators. There is no
full international consensus on the indicators to be used for
assessing iron status, as each indicator has its own limita-
tions because of either poor sensitivity or specificity, or
because it is modified by conditions other than ID (Dallman
et al., 1993). There are three general approaches to assess
ID in populations. In the first one, used in studies conducted
by Hallberg et al. (Hallberg et al., 1993) and Amstrong
(Amstrong, 1989), ID is defined as a low level of serum
ferritin (SF). In the second one, used in the US in the
National Health and Nutrition Examination Survey
(NHANES) II and III, the multiple-criteria model is used to
classify ID; it consists of two or three abnormal values for
transferrin saturation, SF and erythrocyte protoporphyrin
(Cogswell et al., 2009). The main limitation of these two
approaches is that inflammation leads to high ferritin values,
even though iron stores are low. The third approach
proposed by WHO (2004) and adopted by Zimmermann
(2008) is based on the measurements of SF and soluble
transferrin receptor (sTfR) in combination with C-reactive
protein (CRP) to eliminate false negative cases in presence of
inflammation. The third approach was considered more
appropriate and was therefore used in the present study. It is
well known that SF concentrations reflect the size of the iron
stores (Cook, 1999) and that low SF levels identify ‘iron depletion’
(WHO, 2001). On the other hand, the measurement of sTfR
has been reported to be useful in the diagnosis of ‘tissue ID’
(Skikne et al., 1990) and its values are not influenced by acute
or chronic inflammatory conditions (Ferguson et al., 1992;
Olivares et al., 1995). An approach to estimate body iron was
developed by Cook et al. (Cook et al., 2003) using the
formula: body iron (mg/kg)¼ (log(sTfR/SF) 2.8229)/
0.1207 to allow the full range of the iron status of a
population to be evaluated ,with negative values represent-
ing a deficit of iron with respect to the quantity required to
maintain a normal haemoglobin (Hb) concentration.
Adolescents are at risk of ID because of their high iron
requirements, especially during the growth spurt period
(Moreno, 2008). In boys, increased muscular growth leads to
increased demand for iron. In girls, in addition to the fast
growth, the onset of menstruation leads to iron losses
(Wharton and Wharton, 1987). As a consequence, ID occurs
in adolescents also in developed countries, if their additional
iron needs are not met (Dallman et al., 1996). Some studies
suggested that ID can have detrimental effects on memory
and learning processes in preadolescents and adolescents
(Beard and Connor, 2003).
The data available on iron status in European adolescents,
are derived from studies utilising different methodologies,
different indicators of iron status and varying criteria to
define ID (Hercberg et al., 2001). There was, therefore, a need
to investigate the situation of ID among European adoles-
cents with a harmonised methodology.
Within the framework of the HELENA Study (Healthy
Lifestyle in Europe by Nutrition in Adolescents), funded
within the 6th EU framework programme, a biochemical
evaluation of iron status was performed with a cross-
sectional approach. The objective of the present paper is to
report the iron status of European adolescents.
Materials and methods
Study design and sample selection
A detailed description of HELENA-cross-sectional study
(HELENA-CSS) in terms of sampling and recruitment
approaches, standardisation and harmonisation processes,
data collection, analysis strategies and quality-control activ-
ities has been published elsewhere (Moreno et al., 2008).
The study was approved by the Research Ethics Committees
of each country involved according to the Declaration of
Helsinki and International Conferences on Harmonization
for Good Clinical Practice. Written informed consent
was obtained from the parents of the adolescents and the
adolescents themselves (Be ´ghin et al., 2008). Briefly, subjects
with an age range of 12.5–17.49 years were recruited in 10
cities across Europe. Selection of cities was based on two
criteria: regional distribution and presence of an active
research group assuring sufficient expertise and resources
to successfully perform epidemiological studies. Within the
study, Stockholm (Sweden) represented Northern Europe.
Athens, Heraklion (Greece), Rome (Italy) and Zaragoza
(Spain) represented Southern Europe. Pecs (Hungary) repre-
sented Eastern Europe. Ghent (Belgium) and Lille (France)
represented Western Europe, whereas Dortmund (Germany)
and Vienna (Austria) represented Central Europe. As the
overall aim of the HELENA Study was to assess the
nutritional status of the adolescent population in Europe,
during the design phase, the variability of a large set of
nutritional status indices obtained in previous studies was
checked. Body mass index was the indicator that showed the
largest variability. Therefore, the sample size was estimated
according to the mean body mass index and variance values
for each sex and age strata. This procedure ensured
to adequately describe all the variables included in the
study. For the sample size calculation, a confidence level of
95% and an error of ± 0.3kg/m
2 were assumed, leading to a
sample size of 3000 adolescents. More details on the
procedure are provided by Moreno et al. (2008).
Blood sampling was performed in one-third of the
adolescents recruited. Therefore, the total expected
subsample was 1000 adolescents (100 subjects for each city).
The size of subsample was chosen, so as to assess the
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parameters were those with the highest variability within the
blood measurements that were included in the study as
discussed by Moreno et al. (2008). The selection procedure
for schools and classes including the selection of a subset of
classes for blood sampling has been applied centrally by one
partner (Ghent) for all study centres.
Blood sampling and laboratory measures
The blood sampling procedure and sample logistics have been
described in detail elsewhere (Gonza ´lez-Gross et al., 2008).
Briefly, fasting blood samples were collected by venipuncture
at school between 0800 and 1000 hours in the morning.
Whole-blood samples for the red blood parameters (Hb, red
blood cell, mean corpuscular volume (MCV), mean corpus-
cular haemoglobin (MCH), mean corpuscular haemoglobin
concentration and red cell distribution width) were sent
directly to the local laboratory of each country to be analysed.
Samples for iron status analyses were clotted at room
temperature for at least 30min, followed by centrifuged at
3500r.p.m. for 10min. Serum samples were shipped to the
central laboratory in Bonn University (IEL, Germany),
Department of Nutrition and Food Science, to be stored at
 801C before being shipped to Italy in May 2007, within 6
months of the collection. The aliquots of serum samples were
analysed in the Human Nutrition Laboratory of the National
Research Institute on Food and Nutrition (INRAN). SF, sTfR
and CRP were measured by using an enzyme linked
immunosorbent assay (Erhardt et al., 2004). A commercially
available control sample from Bio-Rad Liquichek Immuno-
logy Control Level 3 (Bio-Rad, Milan, Italy) was used to obtain
a calibration curve on each plate.
A quality-control serum was produced in house by pooling
human serum from four healthy volunteers to monitor
accuracy and precision of the determinations. The coeffi-
cient of variation from 10 replicates of the quality-control
serum pool was 5.3, 6.4 and 12.4% for SF, sTfR and CRP,
respectively. Additionally, the interassay coefficient of varia-
tion of the pool samples analysed in a total of 32 different
analytical runs (four replicates) was 10.8, 14.8 and 23.4%
for SF, sTfR and CRP, respectively.
INRAN laboratory is involved in an external quality
assurance program of CDC Vital-Eqa for SF, sTfR and CRP
analyses (Haynes et al., 2008). In Spring 2007, the measures
of iron indicators of this study were within the acceptable
range, except for CRP that was just below the inferior limit
(2.42mg/l versus an acceptable range of 2.70–5.38mg/l) and
sTfR that was at the superior limit (7.3mg/l versus an
acceptable range of 1.7 and 7.3mg/l).
Anaemia and iron classification
Anaemia was defined as Hb concentration below the cutoff
set by WHO (WHO, 2004), 12.0g/dl for girls aged 12 years
and above, and for boys aged 12–14; and 13.0g/dl for
boys aged 15 years or above. Abnormal values for iron
indicators were defined as concentration o15mg/l for low
SF (WHO, 2004), 4200mg/l and 4150mg/l (boys and girls,
respectively) for high SF (WHO, 2004; severe risk of iron
overload) and 48.5mg/l for high sTfR (Cook et al., 1993).
A participant was considered to have active inflammation, if
the CRP concentration exceeded 5mg/l (Woodruff et al., 2006).
The methodology to classify the iron status is described in
Table 1. The classification of iron status is considered in
presence of normal CRP concentration.
Total body iron was estimated with the use of the
formula: body iron (mg/kg)¼ (log(sTfR/SF) 2.8229)/
0.1207 (Cook et al., 2003).
Statistical analyses
The Kruskal–Wallis test was used for comparing haematolo-
gical parameters among iron sufficiency, iron depletion and ID.
The Student’s t-test was used to evaluate the significance of
differences between mean values of iron indicators between
genders. Pearson correlation was used to test the linear
relation between haematological variables. The w
2-test was
used for comparing proportions. Iron status indicators,
such as sTfR and SF, were transformed to logarithms
before performing statistical analyses. The results in the
tables are shown using the original units without any log
transformation.
As already performed by Ortega et al. (Ortega et al., 2010),
all the analyses conducted on the HELENA data were
adjusted by a weighing factor to balance the sample
according to the age and sex distribution of the theoretical
sample to guarantee representation of each of the stratified
groups. The counts of subjects (n) are reported in the tables
as unweighted values. All the statistical analyses were
performed using the SPSS statistical software package for
Microsoft Windows (version 12.00, SPSS Inc., Chicago, IL, USA).
Results
Iron indicators and iron status
The HELENA-CSS consists of 1089 adolescent subjects with
blood measurements. A total of 102 subjects were excluded
Table 1 Iron status
a as defined in the present paper
Classification Values of iron indicators
SF (mg/l) sTfR (mg/l)
Iron sufficiency
b X15 p8.5
Iron depletion
c o15 p8.5
ID
b o15 48.5
IDA o15 48.5
Abbreviations: CRP, C-reactive protein; ID, iron deficiency; IDA, iron deficiency
with anaemia; SF, serum ferritin; sTfR, soluble transferrin receptor.
aIron status is considered in the presence of CRPo5mg/l.
bWith or without anaemia.
cWithout ID and with or without anaemia.
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sTfR, n¼84) or Hb (n¼16) was missing. The final
sample of 987 adolescents included 465 boys and 522 girls,
that is, 90.7% of the adolescents who participated in the
blood sampling.
A total of 47 subjects had high levels of CRP (27 boys and
20 girls) and were excluded. Therefore, the present study of
iron status was performed on a total of 940 adolescents
(438 boys and 502 girls), with no indication of the presence
of inflammation.
The mean age (standard deviation) of adolescents was 14.7
(1.2) years both in boys and in girls, and the mean body mass
index was 21.2 (3.8) and 21.1 (3.3) kg/m
2, respectively, for
boys and girls. The reported age of menarche in the present
study ranged from 9 to 16 years of age. A total of 58 (12%)
girls reported not to have experienced menarche at the time
of the study. In all, 39 and 43% of the boys and girls,
respectively, declared to have smoked cigarettes at least once.
Mean, median and percentiles (25–75th) values of red blood
parameters, SF and sTfR are summarised in Table 2. Percen-
tage of iron sufficiency, abnormal values of iron indicators,
anaemia, iron depletion, ID and iron deficiency anaemia
(IDA) are presented in Table 3.
In boys, the mean (standard deviation) of Hb was 14.7 (1.2)
g/dl (14.3 (1.0) g/dl aged 12.5–14.99 years and 15.2 (1.2) g/dl
aged 15 years or above). In girls it was 13.8 (1.2) g/dl. The mean
values of SF suggest a gender-related significant difference
(Po0.05) with a lower mean SF value in girls (27.9mg/l) than in
boys (36.6mg/l). The percentage of low SF values was also
higher in girls (26.3%) compared with boys (17.9%) (Po0.01)
(Table 3). No single case of high level of SF was identified
(SF4200mg/l for boys and 4150mg/l for girls), indicating no
risk of iron overload (WHO, 2004) in the study sample.
A total of 23 subjects had high values (48.5mg/l) of sTfR
(that could have indicated ID) but with normal values
of SF (indicating no iron depletion), and could therefore not
be categorised in one of the iron status classifications
(Table 1). They were excluded from the analyses in terms
of the classification of ID.
The percentage of iron depletion was 17.6%, significantly
higher in girls (21.0%) than in boys (13.8%) (Po0.05)
(Table 3).
The overall prevalence of anaemia was 4.4% and it ranged
from 1.1% (Stockholm) to 10.1% (Heraklion) among cities.
Intermediate prevalences were 1.4% for Zaragoza, 3.2% for
Pecs, 3.6% for Dortmund, 4.0% for Rome, 4.6% for Ghent,
5.5% for Lille, 5.6% for Vienna and 5.7% for Athens. The
overall prevalence of anaemia without ID was 3.1% (4.6% in
girls and 1.4% in boys) and ranged from 0% (Stockholm and
Zaragoza) to 7.6% (Heraklion). The second highest
prevalence was observed in Athens (5.7%). Intermediate
Table 2 Haemoglobin, red blood and iron status parameters in European adolescents
a
Parameter Boys (n¼438)
b Girls (n¼502)
b
M s.d. Me 25–75th percentiles M s.d. Me 25–75th percentiles
Hb g/dl 14.7 1.2 14.7 14.0–15.6 13.8 1.2 13.4 12.8–14.1
RBC 10
12/l 5.2 0.4 5.1 4.9–5.4 4.7 0.4 4.7 4.5–4.9
MCV fl 83.6 4.6 84.0 81.5–86.2 84.9 5.1 85.5 82.4–88.2
MCH pg 28.6 1.9 28.8 27.7–29.8 28.6 2.1 29.0 29.0–30.0
MCHC g/dl 34.3 1.0 34.2 33.6–34.9 33.7 1.0 33.7 33.7–34.3
RDW % 12.9 0.9 12.9 12.5–13.3 12.9 1.1 12.8 12.8–13.4
SF mg/l 36.6* 23.9 32.0 17.9–49.3 27.9 19.7 24.1 24.1–38.0
STfR mg/l 5.9 1.9 5.8 4.6–7.0 6.0 3.3 5.7 5.7–7.0
Abbreviations: Hb, haemoglobin; M, mean; Me, median; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration;
MCV, mean corpuscular volume; RBC, red blood cells; RDW, red cell distribution width; SF, serum ferritin; sTfR, soluble transferrin receptor.
aAll data were adjusted by a weighing factor to balance the sample according to the theoretical age distribution of the European adolescent population.
bThe count of subjects (n) are reported in the table as unweighted values.
The data are presented as M, s.d., Me and 25th and 75th percentiles
*Po0.05 statistically significant difference between mean values in boys and girls.
Table 3 Proportion of European adolescents having anaemia, abnormal
values of iron indicators, iron sufficiency, iron depletion, ID and IDA
a
Iron status
c Total (n¼940)
b Boys (n¼438)
b Girls (n¼502)
b
n % n % n %
Low SF 210 22.4 78 17.9** 132 26.3
High sTfR 66 7.0 30 6.9 36 7.2
Anaemia 41 4.4 8 1.8** 33 6.6
Classification
d
Iron sufficiency 705 75.2 344 79.3
* 361 71.7
Iron depletion 167 17.6 63 13.8* 104 21.0
ID 45 4.7 18 3.9 27 5.4
IDA 11 1.3 2 0.5 9 2.0
Abbreviations: ID, iron deficiency; IDA, iron deficiency with anaemia;
SF, serum ferritin; sTfR, soluble transferrin receptor.
aAll data were adjusted by a weighing factor to balance the sample according
to the theoretical age distribution of the European adolescent population.
bThe count of subjects (n) are reported in the table as unweighted values.
cIndicators and cutoff values used to identify abnormal values of iron
indicators and iron status are reported in Table 1.
d23 subjects (13 boys and 10 girls) were excluded because of with high values
of sTfR and normal values of SF.
*Po0.05; **Po0.01 statistically significant between girls and boys.
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for Rome, 3.2% for Pecs, 4.1% for Lille and 4.6% for Ghent.
Percentage of iron depletion ranged from 9.6% (Zaragoza) to
23.0% (Pecs). Percentage of ID ranged from 0% (Lille) to
11.3% (Athens). Percentage of IDA ranged from 0% (Athens,
Gent, and Pecs) to 2.8 % (Vienna).
Among adolescents with anaemia (n¼40), 27.5% (n¼11)
were classified as IDA, with abnormal SF and sTfR values,
whereas 24.3% (n¼10) had abnormal SF values but with
normal sTfR values (iron depletion without ID) and 47.5%
(n¼19) had anaemia without ID, with normal SF and sTfR
values.
Log(SF) and log(sTfR) were significantly correlated with
the red cell parameters (MCV, MCH, mean corpuscular
haemoglobin concentration and red cell distribution width)
(Table 4). In the total sample, a significant correlation was
observed between log(SF) and Hb concentration (r¼0.36,
Po0.01), and between log(SF) and log(sTfR) (r¼0.33,
Po0.01). For log(sTfR), a significant correlation was observed
with log(SF), MCH (r¼ 0.30, Po0.01) and MCV (r¼ 0.26,
Po0.01) No significant correlation was observed between red
blood cell and iron indicators (log(SF) and log(sTfR); r¼0.13
and r¼0.07, respectively).
The mean of red cell parameters in the different classifica-
tion of iron status is reported in Table 5. Statistically
significant differences between iron sufficiency, iron
depletion and ID were observed for red cell parameters for
boys and girls. There were significant differences (Po0.001)
for Hb, MCV, MCH, mean corpuscular haemoglobin
concentration and red cell distribution width between
iron sufficiency group and the iron depletion and ID
groups. No significant difference was observed between
iron sufficiency group and ID group for any of the red cell
parameters considered.
Estimation of body iron
Body iron was calculated according to the formula of Cook
et al. (Cook et al., 2003), and the cumulative percentage
distributions by gender are shown in Figure 1. Mean
Table 4 Pearson correlation coefficients and significance of correlations (P) between iron parameters
a (n¼940)
b
Hb RBC MCV MCH MCHC RDW Log(SF) Log(sTfR)
Boys
Log(SF) 0.25** 0.11* 0.17** 0.19** 0.10**  0.14** —  0.25**
Log(sTfR) 0.16** 0.07  0.16**  0.22**  0.20** 0.09**  0.25** —
Girls
Log(SF) 0.35** 0.004* 0.34** 0.41** 0.40**  0.42** —  0.39**
Log(sTfR) 0.21** 0.11  0.32**  0.35**  0.29** 0.35**  0.39** —
Total
Log(SF) 0.36** 0.13 0.24** 0.32** 0.32**  0.31** —  0.33**
Log(sTfR) 0.16** 0.07  0.26**  0.30**  0.24** 0.26**  0.33** —
Abbreviations: Hb, haemoglobin; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration; MCV, mean corpuscular volume;
RBC, red blood cells; RDW, red cell distribution width; SF, serum ferritin; sTfR, soluble transferrin receptor.
aAll data were adjusted by a weighing factor to balance the sample according to the theoretical age distribution of the European adolescent population.
bThe count of subjects (n) are reported in the table as unweighted values.
*Po0.05; **Po0.01 boys versus girls.
Table 5 Haematological characteristics according to iron sufficiency, iron depletion and ID
a
Iron sufficiency Iron depletion ID
Boys
(n¼344)
b
Girls
(n¼361)
b
Total
(n¼705)
b
Boysc
(n¼63)
b
Girls
(n¼104)
b
Total
(n¼167)
b
Boys
(n¼18)
b
Girls
(n¼27)
b
Total
(n¼45)
b
Mean Hb, g/dl (s.d.) 14.9 (1.2) 13.6 (0.9) 14.2 (1.2)* 14.4 (1.0) 13.3 (1.6) 13.7 (1.4) 13.7 (0.9) 12.0 (1.4) 12.7 (1.4)
Mean RBC, 10
12/l (s.d.) 5.2 (0.4) 4.7 (0.3) 4.9 (0.4) 5.2 (0.4) 4.7 (0.5) 4.8 (0.5) 5.0 (0.4) 4.8 (0.3) 4.8 (0.4)
Mean MCV, fl (s.d.) 84.1 (4.4) 85.7 (4.6) 84.8 (4.5)* 82.1 (4.6) 84.5 (4.5) 83.4 (4.7) 82.0 (4.2) 78.2 (8.0) 80.1 (6.4)
Mean MCH, pg (s.d.) 28.8 (1.8) 29.0 (1.8) 28.8 (1.8)* 28.0 (1.9) 28.3 (1.8) 28.3 (1.9) 27.6 (1.7) 25.1 (3.5) 26.3 (2.9)
Mean MCHC, g/dl (s.d.) 34.3 (1.0) 33.8 (0.9) 34.1 (0.9)* 34.1 (1.0) 33.5 (0.9) 33.7 (1.0) 33.6 (1.0) 32.0 (1.8) 32.8 (1.6)
Mean RDW, % (s.d.) 12.9 (0.9) 12.7 (0.9) 12.8 (0.9)* 13.2 (1.0) 13.2 (1.0) 13.2 (1.0) 13.6 (0.9) 14.6 (2.0) 14.1 (1.6)
Abbreviations: Hb, haemoglobin; ID, iron deficiency; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration;
MCV, mean corpuscular volume; RBC, red blood cells; RDW, red cell distribution width.
aAll data were adjusted by a weighing factor to balance the sample according to the theoretical age distribution of the European adolescent population.
bThe count of subjects (n) are reported in the table as unweighted values.
*Po0.001 statistically different between iron sufficiency, iron depletion and ID.
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(Po0.001; Student’s t-test) in boys (4.4 (3.2) mg/kg) than
in girls (3.3 (4.1) mg/kg). Girls showed a light shift of
the body iron distribution curve to the left in comparison
with boys in which higher positive values were observed.
The reference line indicates the cutoff point for tissue ID
(body iron o0mg/kg). The percentage of negative values was
significantly higher (Po0.001; w
2) in girls (16.5%) with
respect to boys (8.3%).
The distribution of body iron stores by age was also
examined. Figure 2 shows that the linear relationship
between the body iron and the age of the adolescents
is not very strong. The body iron increased slightly with
age (r¼0.28) but this trend did not reach statistical
significance. On the other hand, it tended to be stable
(r¼0.025) in girls.
Discussion
The present study is the first report evaluating iron status in
adolescents across multiple European countries. As discussed
by Moreno et al. (2008), the selected cities were equivalent
and comparable between countries but the samples were
representative for the cities and not for the countries.
Therefore, the HELENA Study does not allow for statistical
comparison of differences in iron status between regions.
However, the prevalence of iron status stages according to
geographical location of the cities adopted for this study are
provided underneath for descriptive purpose.
In the present study, the overall proportion of iron
depletion was 17.6%; it was significantly higher in girls
(21.0%) than in boys (13.8%). The prevalence of iron
depletion by geographical location was: 23% in Eastern
Europe (Pecs), 19% in Northern Europe (Stockholm), 18%
in Western Europe (17% in Ghent and 19% in Lille), 17% in
Central Europe (16% in Dortmund and 19% in Vienna) and
15% in Southern Europe (14% in Athens, 17% in Heraklion,
19% in Rome and 10% in Zaragoza). These data are in the
range of findings from a recent review on iron status in
European adolescents (Hercberg et al., 2001) where the
highest prevalence of iron depletion was observed in girls
in Ireland (43%) and in boys in Denmark (16%), whereas the
lowest prevalence was observed in girls in Finland (4.7%) and
in boys in France where no cases were detected.
For ID, in the present study, there was a tendency for a
higher percentage in girls (5.4%) with respect to boys (3.9%)
but the difference was not significant. The percentage of ID
in girls in our study was slightly lower than the 8.7%
prevalence observed in girls aged 12–16 years in the US
(Halterman et al., 2001) but in line with the 6% prevalence
observed in girls aged 13–19 years in Canada (Deegan et al.,
2005). Both the prevalences observed in our study and in the
US are below the cutoff established by WHO to determine
‘no prevalence’ of ID, that is, 10% (WHO, 2004). Both are
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Figure 1 Cumulative percentage distributions of estimated body
iron in boys and girls from the HELENA Study. Total body iron
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ferritin ratio) 2.8229)/0.1207 developed by Cook (1999) Positive
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as in Nepal, with an ID prevalence of 56% observed in
adolescents girls (Woodruff et al., 2006). The slightly lower
prevalence in our study may, in part, result from a different
approach to define ID. The impact of ID on the cognitive
functioning of adolescent girls who are at the highest risk of
ID requires major clarification. In fact, there is only limited
evidence that iron supplementation may improve attention,
concentration and intelligent quotient (Falkingham et al.,
2010). The prevalence of ID by geographical location was:
6% in both Northern Europe (Stockholm) and Southern
Europe (11% in Athens, 6% in Heraklion, 3% in Rome and
Zaragoza) plus Eastern Europe (Pecs), 5% in Central Europe
(3% in Dortmund and 7% in Vienna) and 2% in Western
Europe (no cases in Ghent and 4% in Lille). No comparable
data are available in the literature in relation to ID in
adolescents in the European context for comparison with
the results of the present study.
The percentage of IDA was 1.3% (0.5% in boys and 2.0% in
girls), with a (non-significantly) higher value in girls. The
prevalence of IDA by geographical location was: 2% in
Central Europe (2% in Dortmund and 3% in Vienna), 1% in
both Northern Europe (Stockholm) and Southern Europe
(no cases in Athens, 2% in Heraklion, 1% in both Rome and
Zaragoza), 0.6% in Western Europe (no cases in Ghent and
1% in Lille) and no cases in Eastern Europe (Pecs). These data
are similar to the estimates of prevalence in adolescents in
Canada (Deegan et al., 2005), the United States (Looker et al.,
2002) and Sweden (Samulson et al., 1996), ranging from
0 to 3%. In the present study, the proportion of anaemia was
4.4%, consistent with the estimates of the worldwide
prevalence of anaemia during adolescence: 27% in develop-
ing countries and 6% in developed countries (Kara et al.,
2006). The observed prevalence of anaemia not due to ID
(3.1%) is probably overestimated because of unavoidable
misclassifications that are inherent to the definition of
limits. In fact, the limits set to define anaemia are based
on 95% reference ranges, and therefore it is assumed that
2.5% of healthy individuals would be classified as anaemic.
On the other hand, a proportion of anaemia without ID
may be originated from genetic Hb disorders, as subjects
with such disorders were not excluded. In our study,
the highest prevalence of anaemia without ID among cities
was observed in two cities of Greece (7.6% in Heraklion and
6.3% in Athens). Greece is known to be heavily affected by
haemoglobinopathies (thalassaemia and sickle-cell disease).
In fact, according to Angastiniotis et al. (1995), the highest
percentage of carriers of thalassaemia and sickle-cell
disorders is observed in Greece (9.0%).
In our study, no single case of iron overload was identified
through SF, a stored body iron marker.
Results of the present study on correlations between
iron status parameters are all plausible. SF and sTfR that
were chosen in this study as iron indicators showed a
correlation with red cell parameters. The observed corre-
lation coefficients between log(sTfR) and red cell parameters
(MCVand MCH) are not surprising, as sTfR is a measure of ID
erytropoiesis (Metzgeroth et al., 2005) as MCVand MCH. The
present data are in general agreement with the result of a
previous study showing a correlation between sTfR and red
cell parameters in iron-deficient adolescents (Choi, 2003).
These findings are confirmed, as the concentrations of the
mean of red cell parameters decreased gradually (except for
red cell distribution width that increased) with increasingly
negative iron balance, as ID appeared (sTfR 48.5mg/l)
(Table 5). The results of the present study document a
positive correlation between log(SF) level and Hb concentra-
tion (r¼0.39, Po0.01; Table 3) comparable to those
observed in other studies among children: r¼0.24 (Jeremiah
et al., 2007) and r¼0.26 (Ayoya et al., 2010). The low
correlation between these two indicators is because of
the fact that they are related to differing stages of ID. The
correlation between the indicators of iron status and red cell
parameters may be considered as a confirmation of the
reliability of these indicators (WHO, 2004; Zimmermann,
2008) in the assessment of iron status in adolescents.
The correlation of SF with Hb and the higher percentage of
iron depletion in girls with respect to boys suggest that
the risk of developing ID anaemia is higher in girls. If iron
depletion is not corrected, it may indeed progress to ID. In
addition, the calculated measure of body iron was lower in
girls than in boys. The distribution of body iron stores by age
(Figure 2) suggests that in boys, body iron stores may have
slightly increased during and after their rapid growth
period, whereas in girls, iron stores remain low during the
whole pubertal period. One possible explanation for the
lower iron status in girls, besides growth, is the loss of iron
with menstruation. In previous studies, it was observed that
the growth spurt associated with menstrual status, blood loss
and a low iron intake may have adverse effects on iron stores
in adolescents girls (Ilich-Ernst et al., 1998).
Conclusions
Our study confirms SF and sTfR as biochemical indicators
that could be used in the assessment of iron status in
adolescents, a problematic group of population, for the
period of rapid growth. On the basis of WHO guidelines
(2004) for the interpretation of the iron status data at
population level, the results indicate that, in the European
context, ID is not prevalent neither in boys nor in girls, and
that iron depletion is prevalent in girls but not in boys.
Adolescent girls therefore constitute a group at risk of ID,
and specific attention should be given to them during
adolescence to ensure that their dietary intake of iron is
adequate to their requirements.
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